TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Internet-based Self-management Program With Telephone Support for Adolescents With Arthritis: A Pilot Randomized Controlled Trial
Brief Summary: This study will evaluate the feasibility of "Teens Taking Charge: Managing Arthritis On-line" intervention that will help adolescents with arthritis to better manage their disease and improve their health-related quality of life (HRQL).


Options:
A: Arm Label: Wait List; Type: OTHER; Interventions: Behavioral: Wait list comparison group | Arm Label: 2 phone sessions; Type: EXPERIMENTAL; Interventions: Behavioral: 2 Family-based problem solving phone sessions | Arm Label: 4 phone sessions; Type: EXPERIMENTAL; Interventions: Behavioral: 4 Family-based problem solving phone intervention sessions | Intervention Type: BEHAVIORAL; Name: 2 Family-based problem solving phone sessions; Assigned to Arm(s): 2 phone sessions | Intervention Type: BEHAVIORAL; Name: 4 Family-based problem solving phone intervention sessions; Assigned to Arm(s): 4 phone sessions | Intervention Type: BEHAVIORAL; Name: Wait list comparison group; Assigned to Arm(s): Wait List
B: Arm Label: Internet-based JIA Self-Management Program; Type: EXPERIMENTAL; Interventions: Behavioral: Teens Taking Charge | Arm Label: Attention Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-Management | Intervention Type: BEHAVIORAL; Name: Teens Taking Charge; Assigned to Arm(s): Internet-based JIA Self-Management Program | Intervention Type: BEHAVIORAL; Name: Self-Management; Assigned to Arm(s): Attention Control Group
C: Arm Label: SLCBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy & Social Learning | Arm Label: SLCBT-R; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy & Social Learning | Arm Label: ES; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education and Support | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy & Social Learning; Assigned to Arm(s): SLCBT, SLCBT-R | Intervention Type: BEHAVIORAL; Name: Education and Support; Assigned to Arm(s): ES
D: Arm Label: Standard of Care Observation Group; Type: N/A; Interventions: N/A | Arm Label: Biopsychosocial Intervention Group; Type: N/A; Interventions: Behavioral: Brief Cognitive-Behavioral Pain Management Training | Intervention Type: BEHAVIORAL; Name: Brief Cognitive-Behavioral Pain Management Training; Assigned to Arm(s): Biopsychosocial Intervention Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Internet-based Self-management Program With Telephone Support for Adolescents With Arthritis: A Pilot Randomized Controlled Trial
Brief Summary: This study will evaluate the feasibility of "Teens Taking Charge: Managing Arthritis On-line" intervention that will help adolescents with arthritis to better manage their disease and improve their health-related quality of life (HRQL).


Options:
A: Arm Label: Coping Skills; Type: EXPERIMENTAL; Interventions: Behavioral: Coping Skills Training | Arm Label: Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Coping Skills Training; Assigned to Arm(s): Coping Skills | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education
B: Arm Label: Coping Skills Training + Amitriptyline; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Coping Skills Training, Drug: Amitriptyline | Arm Label: Headache Education + Amitriptyline; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Headache Education, Drug: Amitriptyline | Intervention Type: BEHAVIORAL; Name: Coping Skills Training; Assigned to Arm(s): Coping Skills Training + Amitriptyline | Intervention Type: BEHAVIORAL; Name: Headache Education; Assigned to Arm(s): Headache Education + Amitriptyline | Intervention Type: DRUG; Name: Amitriptyline; Assigned to Arm(s): Coping Skills Training + Amitriptyline, Headache Education + Amitriptyline
C: Arm Label: Internet-based JIA Self-Management Program; Type: EXPERIMENTAL; Interventions: Behavioral: Teens Taking Charge | Arm Label: Attention Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-Management | Intervention Type: BEHAVIORAL; Name: Teens Taking Charge; Assigned to Arm(s): Internet-based JIA Self-Management Program | Intervention Type: BEHAVIORAL; Name: Self-Management; Assigned to Arm(s): Attention Control Group
D: Arm Label: SLCBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy & Social Learning | Arm Label: SLCBT-R; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy & Social Learning | Arm Label: ES; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education and Support | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy & Social Learning; Assigned to Arm(s): SLCBT, SLCBT-R | Intervention Type: BEHAVIORAL; Name: Education and Support; Assigned to Arm(s): ES

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Internet-based Self-management Program With Telephone Support for Adolescents With Arthritis: A Pilot Randomized Controlled Trial
Brief Summary: This study will evaluate the feasibility of "Teens Taking Charge: Managing Arthritis On-line" intervention that will help adolescents with arthritis to better manage their disease and improve their health-related quality of life (HRQL).


Options:
A: Arm Label: FitNet treatment; Type: EXPERIMENTAL; Interventions: Behavioral: FitNet treatment | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Intervention Type: BEHAVIORAL; Name: FitNet treatment; Assigned to Arm(s): FitNet treatment | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care
B: Intervention Type: DRUG; Name: citalopram; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: BuproprionSR; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: buspirone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Lithium; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: mirtazapine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: nortriptyline; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: sertraline; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: tranylcypromine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: VenlafaxineXR; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Therapy; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: T3 (Triiodothyronine); Assigned to Arm(s): N/A
C: Arm Label: IPT arm; Type: EXPERIMENTAL; Interventions: Behavioral: interpersonal psychotherapy for groups | Arm Label: CP arm; Type: EXPERIMENTAL; Interventions: Behavioral: creative play therapy | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: interpersonal psychotherapy for groups; Assigned to Arm(s): IPT arm | Intervention Type: BEHAVIORAL; Name: creative play therapy; Assigned to Arm(s): CP arm
D: Arm Label: Internet-based JIA Self-Management Program; Type: EXPERIMENTAL; Interventions: Behavioral: Teens Taking Charge | Arm Label: Attention Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-Management | Intervention Type: BEHAVIORAL; Name: Teens Taking Charge; Assigned to Arm(s): Internet-based JIA Self-Management Program | Intervention Type: BEHAVIORAL; Name: Self-Management; Assigned to Arm(s): Attention Control Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Internet-based Self-management Program With Telephone Support for Adolescents With Arthritis: A Pilot Randomized Controlled Trial
Brief Summary: This study will evaluate the feasibility of "Teens Taking Charge: Managing Arthritis On-line" intervention that will help adolescents with arthritis to better manage their disease and improve their health-related quality of life (HRQL).


Options:
A: Arm Label: Coping Skills; Type: EXPERIMENTAL; Interventions: Behavioral: Coping Skills Training | Arm Label: Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Coping Skills Training; Assigned to Arm(s): Coping Skills | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education
B: Arm Label: Coping Skills Training + Amitriptyline; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Coping Skills Training, Drug: Amitriptyline | Arm Label: Headache Education + Amitriptyline; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Headache Education, Drug: Amitriptyline | Intervention Type: BEHAVIORAL; Name: Coping Skills Training; Assigned to Arm(s): Coping Skills Training + Amitriptyline | Intervention Type: BEHAVIORAL; Name: Headache Education; Assigned to Arm(s): Headache Education + Amitriptyline | Intervention Type: DRUG; Name: Amitriptyline; Assigned to Arm(s): Coping Skills Training + Amitriptyline, Headache Education + Amitriptyline
C: Arm Label: Social learning and cognitive behavioral therapy (SLCBT); Type: EXPERIMENTAL; Interventions: Behavioral: Social Learning and Cognitive Behavioral Therapy (SLCBT) | Arm Label: Education Support (ES); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education Support (ES) | Intervention Type: BEHAVIORAL; Name: Social Learning and Cognitive Behavioral Therapy (SLCBT); Assigned to Arm(s): Social learning and cognitive behavioral therapy (SLCBT) | Intervention Type: BEHAVIORAL; Name: Education Support (ES); Assigned to Arm(s): Education Support (ES)
D: Arm Label: Internet-based JIA Self-Management Program; Type: EXPERIMENTAL; Interventions: Behavioral: Teens Taking Charge | Arm Label: Attention Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-Management | Intervention Type: BEHAVIORAL; Name: Teens Taking Charge; Assigned to Arm(s): Internet-based JIA Self-Management Program | Intervention Type: BEHAVIORAL; Name: Self-Management; Assigned to Arm(s): Attention Control Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The participation in this clinical study will last approximately 21 weeks with a 1 week screening period and a 12 weeks treatment duration. If the study doctor finds, that the patients disease has significantly improved he/she will enter a treatment free follow-up period of 8 weeks. In total the study consists of 5 to 6 clinical visits (V1 - V6) and 1 telephone follow-up call.


Options:
A: Arm Label: Dex 21-P; Type: EXPERIMENTAL; Interventions: Drug: Dex 21-P | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dex 21-P; Assigned to Arm(s): Dex 21-P | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: abatacept | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: abatacept; Type: OTHER; Interventions: Drug: abatacept | Intervention Type: DRUG; Name: abatacept; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: abatacept; Assigned to Arm(s): abatacept
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Golimumab 1 milligram (mg) per kilogram (kg); Type: EXPERIMENTAL; Interventions: Drug: Golimumab 1 mg per kg | Arm Label: Golimumab 2 mg per kg; Type: EXPERIMENTAL; Interventions: Drug: Golimumab 2 mg per kg | Arm Label: Golimumab 4 mg per kg; Type: EXPERIMENTAL; Interventions: Drug: Golimumab 4 mg per kg | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Golimumab 1 mg per kg; Assigned to Arm(s): Golimumab 1 milligram (mg) per kilogram (kg) | Intervention Type: DRUG; Name: Golimumab 2 mg per kg; Assigned to Arm(s): Golimumab 2 mg per kg | Intervention Type: DRUG; Name: Golimumab 4 mg per kg; Assigned to Arm(s): Golimumab 4 mg per kg
D: Arm Label: LT-02 Dose 1; Type: EXPERIMENTAL; Interventions: Drug: LT-02 | Arm Label: LT-02 Dose 2; Type: EXPERIMENTAL; Interventions: Drug: LT-02 | Arm Label: LT-02 Dose 3; Type: EXPERIMENTAL; Interventions: Drug: LT-02 | Arm Label: Sugar pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: LT-02; Assigned to Arm(s): LT-02 Dose 1, LT-02 Dose 2, LT-02 Dose 3 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Sugar pill

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Characterizing Alpha5 Nicotinic Receptors in Alcohol and Nicotine Dependence
Brief Summary: Purpose: This is an outpatient, randomized, double-blinded, placebo-controlled study in which either varenicline (twice daily) or placebo will be administered over a 12 week study period to examine genetic influences on treatment response to varenicline for reduction of hazardous drinking.


Options:
A: Arm Label: varenicline; Type: EXPERIMENTAL; Interventions: Drug: varenicline | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): varenicline | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
B: Arm Label: varenicline and buproprion SR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline, Drug: bupropion SR | Arm Label: varenicline and placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Varenicline, Drug: placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): varenicline and buproprion SR, varenicline and placebo | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): varenicline and placebo | Intervention Type: DRUG; Name: bupropion SR; Assigned to Arm(s): varenicline and buproprion SR
C: Arm Label: varenicline; Type: EXPERIMENTAL; Interventions: Drug: varenicline | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): varenicline | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
D: Arm Label: Varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Arm Label: Sugar Pill or Placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sugar pill or Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Sugar pill or Placebo; Assigned to Arm(s): Sugar Pill or Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin
Brief Summary: The current recommended guideline for patients receiving moderately emetogenic chemotherapy (MEC) is the combination of a 5-HT3 receptor antagonist and corticosteroid. Incidence of chemotherapy induced nausea and vomiting (CINV) is approximately 50% in patients receiving MEC. An incidence rate of 25-38% for delayed emesis and 55-60% for delayed nausea has been observed. Hence, there is clearly a need for more effective prevention of CINV in patients receiving MEC, especially in women with ovarian carcinoma who are particularly susceptible to these symptoms. Therefore the investigators designed a study with the objective to evaluate if new combination (Aprepitant/Ramosetron/Dexamethasone) may improve actual CINV control in ovarian carcinoma patients treated with taxane/carboplatin.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Comparator: fosaprepitant dimeglumine, Drug: Dexamethasone, Drug: Ondansetron | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Comparator: Aprepitant, Drug: Dexamethasone, Drug: Ondansetron | Intervention Type: DRUG; Name: Comparator: fosaprepitant dimeglumine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Comparator: Aprepitant; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Ondansetron; Assigned to Arm(s): 1, 2
B: Arm Label: Aprepitant; Type: EXPERIMENTAL; Interventions: Drug: Aprepitant/Ramosetron/Dexamethasone | Intervention Type: DRUG; Name: Aprepitant/Ramosetron/Dexamethasone; Assigned to Arm(s): Aprepitant
C: Intervention Type: DRUG; Name: MK0869, aprepitant / Duration of Treatment: 3 days; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Comparator: ondansetron / Duration of Treatment: 4 days; Assigned to Arm(s): N/A
D: Arm Label: Arm I; Type: ACTIVE_COMPARATOR; Interventions: Drug: dexamethasone, Drug: Palonosetron Hydrochloride, Other: placebo | Arm Label: Arm II; Type: EXPERIMENTAL; Interventions: Drug: APF530, Drug: dexamethasone, Other: placebo | Arm Label: Arm III; Type: EXPERIMENTAL; Interventions: Drug: APF530, Drug: dexamethasone, Other: placebo | Intervention Type: DRUG; Name: APF530; Assigned to Arm(s): Arm II, Arm III | Intervention Type: DRUG; Name: dexamethasone; Assigned to Arm(s): Arm I, Arm II, Arm III | Intervention Type: DRUG; Name: Palonosetron Hydrochloride; Assigned to Arm(s): Arm I | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): Arm I, Arm II, Arm III

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: RCT colloids versus cristalloids only in severe burn victims.

* Trial with medicinal product


Options:
A: Intervention Type: DRUG; Name: Fluid resuscitation; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: HES 130/0.4 (6%), Voluven balanced vs. Lactated Ringer's solution; Assigned to Arm(s): N/A
B: Arm Label: HES 130/0.4; Type: EXPERIMENTAL; Interventions: Drug: 6% Hydroxyethyl starch 130/0.4 | Arm Label: Ringer acetate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ringers acetate | Intervention Type: DRUG; Name: 6% Hydroxyethyl starch 130/0.4; Assigned to Arm(s): HES 130/0.4 | Intervention Type: DRUG; Name: Ringers acetate; Assigned to Arm(s): Ringer acetate
C: Intervention Type: DRUG; Name: HyperHAES vs. RA-solution/NaCl; Assigned to Arm(s): N/A
D: Arm Label: Hydroxy-ethyl starch; Type: EXPERIMENTAL; Interventions: Drug: 6% Hydroxy-ethyl starch (130/0.4) | Arm Label: Saline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Saline | Intervention Type: DRUG; Name: 6% Hydroxy-ethyl starch (130/0.4); Assigned to Arm(s): Hydroxy-ethyl starch | Intervention Type: DRUG; Name: Saline; Assigned to Arm(s): Saline

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The purpose of this study is to study the efficacy of dexamethasone added to ramosetron for preventing postoperative nausea and vomiting in highly susceptible patients following spine surgery.


Options:
A: Arm Label: Acustimulation; Type: EXPERIMENTAL; Interventions: Device: Transcutaneous electrical acupoint stimulation, Drug: Dexamethasone | Arm Label: Tropisetron; Type: ACTIVE_COMPARATOR; Interventions: Device: Sham transcutaneous electrical acupoint stimulation, Drug: Tropisetron, Drug: Dexamethasone | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Device: Sham transcutaneous electrical acupoint stimulation, Drug: Dexamethasone | Intervention Type: DEVICE; Name: Transcutaneous electrical acupoint stimulation; Assigned to Arm(s): Acustimulation | Intervention Type: DEVICE; Name: Sham transcutaneous electrical acupoint stimulation; Assigned to Arm(s): Control, Tropisetron | Intervention Type: DRUG; Name: Tropisetron; Assigned to Arm(s): Tropisetron | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Acustimulation, Control, Tropisetron
B: Arm Label: Ondansetron; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ondansetron | Arm Label: Granisetron; Type: ACTIVE_COMPARATOR; Interventions: Drug: Granisetron | Intervention Type: DRUG; Name: Ondansetron; Assigned to Arm(s): Ondansetron | Intervention Type: DRUG; Name: Granisetron; Assigned to Arm(s): Granisetron
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: GW679769 (casopitant) | Intervention Type: DRUG; Name: GW679769 (casopitant); Assigned to Arm(s): Arm 1
D: Arm Label: Group A; Type: ACTIVE_COMPARATOR; Interventions: Drug: ramosetron with saline | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Drug: ramosetron with dexamethasone | Intervention Type: DRUG; Name: ramosetron with saline; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: ramosetron with dexamethasone; Assigned to Arm(s): Group B

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Atorvastatin on Endothelial Function, Vascular and Myocardial Redox State in High Cardiovascular Risk Patients
Brief Summary: The present study constitutes a study examining the effect of atorvastatin on vascular function in high cardiovascular risk patients. For this purpose the investigators will record atorvastatin effects on statin-naïve patients (patients that start statins treatment for first time). More specifically the investigators will study atorvastatin effects on:

1. Endothelial function
2. Arterial elastic properties
3. Systemic Inflammatory/thrombotic mechanisms
4. Vascular and myocardial redox state


Options:
A: Arm Label: High dose Atorvastatin 80 mg; Type: EXPERIMENTAL; Interventions: Drug: Atorvastatin | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atorvastatin | Intervention Type: DRUG; Name: Atorvastatin; Assigned to Arm(s): Control, High dose Atorvastatin 80 mg
B: Arm Label: Atorvastatin, Ischemic Heart Disease; Type: OTHER; Interventions: Drug: Atorvastatin, high vs low dose | Arm Label: Atorvastatin vs Placebo Cardiac Surgery; Type: PLACEBO_COMPARATOR; Interventions: Drug: Atorvastatin vs Placebo | Intervention Type: DRUG; Name: Atorvastatin, high vs low dose; Assigned to Arm(s): Atorvastatin, Ischemic Heart Disease | Intervention Type: DRUG; Name: Atorvastatin vs Placebo; Assigned to Arm(s): Atorvastatin vs Placebo Cardiac Surgery
C: Arm Label: statin; Type: EXPERIMENTAL; Interventions: Drug: atorvastatin | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: atorvastatin; Assigned to Arm(s): statin | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
D: Intervention Type: DRUG; Name: Simvastatin; Assigned to Arm(s): N/A

Answer: B